+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-11-15Number of Pages: 170

Atrial Fibrillation Market (Product Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure, Other Products; End User - Hospitals, Electrophysiology Labs, Ambulatory Surgical Center; Application - Diagnostic, EP Ablation, Surgical) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

Atrial fibrillation is becoming common among individuals due to the various factors such as hypertension, high alcohol intake, rising number of people with common diseases such as diabetes and obesity. However, with the growth in atrial fibrillation, the procedures and devices providing diagnoses and treatment are also increasing. Technologically advanced procedures are being adopted by the hospitals and clinics to treat atrial fibrillation. Meanwhile, favorable regulatory steps by the government in various countries is also leading to the rise in adoption of advanced procedures for diagnoses and treatment of atrial fibrillation.

The emergence of new technologies is leading towards high-resolution image and mapping system that can be used to identify complexity across the entire atrial chamber. Similarly, a combination of laser and video technology is also resulting in the high success rate in the treatment of atrial fibrillation. Increasing use of less invasive treatments is resulting in the manufacturers coming up with the new devices for diagnoses and treatment of atrial fibrillation. Catheter ablation is a minimally invasive therapy gaining popularity across the countries. With the quick adoption of catheter ablation, manufacturers are also coming up with new devices that are smart and able to provide treatment in an effective and safer way. Key market players have already launched advanced atrial fibrillation devices in Europe, and are now preparing to launch those devices in the U.S. based on the adoption in Europe.

Global Atrial Fibrillation Market

However, the high cost of treatment and lack of skilled professionals are restricting the growth of atrial fibrillation market. Although, the government in various countries are introducing various programs and regulations to provide treatment for a maximum number of people suffering from atrial fibrillation.  

EP Ablation Catheters Likely to be the Top-Selling Product in the Global Atrial Fibrillation Market

EP ablation catheters are likely to be one of the top-selling products in the global atrial fibrillation market during 2017-2026. By the end of 2026, EP ablation catheters are projected to reach nearly US$ 2,700 million revenue. Meanwhile, EP mapping and recording systems are also likely to witness significant growth during 2017-2026.

Hospital are Likely to Gain Maximum Revenue Share

Hospitals are anticipated to be the largest end-users in the global atrial fibrillation market between 2017 and 2026. Hospitals are projected to surpass US$ 4,400 million revenue by the end of 2026. Although electrophysiology labs are also likely to witness impressive growth during 2017-2026.

EP Ablation to Witness Significant Growth in the Global Atrial Fibrillation Market

EP ablation is likely to account for nearly one-third of the revenue share by the end of 2017. Towards the end of 2026, EP ablation is projected to bring in more than US$ 5,000 million revenue.

Europe to Remain Dominant in the Global Atrial Fibrillation Market between 2017 and 2026

Europe is likely to dominate the global market for atrial fibrillation through 2026. Owing to the rise in the adoption of technologically advanced technologies and advanced healthcare facilities and infrastructure is driving the growth in Europe. Most of the devices often get approval in Europe before entering the U.S. market, hence the region is set to witness robust growth during 2017-2026. Moreover, increasing number of catheter ablation procedures performed in Germany is also contributing to the market growth.

Competition Tracking

The report also offers a detailed profile of various leading companies that are expected to remain active in the expansion of global atrial fibrillation market through 2026, which include Medtronic Plc, Abbott Laboratories, MicroPort Scientific Corporation, Biosense Webster, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, CardioFocus, Inc., Osypka AG, AtriCure Inc., and Koninklijke Philips N.V.  

Global Atrial Fibrillation Market: Overview

Atrial fibrillation is an irregular heartbeat identified by the rapid and abnormal beating of the heart. The global market for atrial fibrillation is majorly driven by the rise in high blood pressure and valvular heart disease. Meanwhile, increasing prevalence of atrial fibrillation among the geriatric population is also fueling the growth of the market. Significant technological advancement is leading to the development of new monitoring technologies that can help patients as well as clinicians to keep a close watch and treat it on time. Smart, wireless, easy-to-use, cost-effective, and efficient monitoring systems are also being focused on to monitor the heartbeat. These developments present a major opportunity for key players operating in atrial fibrillation space.

Innovative technologies with the ability to target the causes of atrial fibrillation have led to the maximum success rate of treating the condition. The key market players are also entering into a partnership with research institutes and other companies to develop an efficient system to detect and treat atrial fibrillation.

Global Atrial Fibrillation Market: Research Methodology

The research is based on primary and secondary research, done for understanding the trends, drivers, opportunity, restraints, etc. The research is done to forecast the expected revenue of the global atrial fibrillation market. Primary research is based on the information collected from interviews and discussions with a number of industry experts and opinion leaders.

Secondary research includes the study of company websites, press releases, annual reports, investor and analyst presentation, and various other factors. The report also offers an estimated market size in terms of US$ Mn for product type, end-user, and application for the forecast period of 2017 to 2026. The report also takes into account the macro and micro factors that are affecting the market. The report also offers Porter’s five force analysis and SWOT analysis. An in-depth analysis of factors resulting in driving and restraining growth of the market and future opportunities has been provided in the report. The report also offers market attractiveness analysis that provides an analysis of the competitive scenario in the global atrial fibrillation market.

Global Atrial Fibrillation Market: Segmentation

The global atrial fibrillation market is segmented on the basis of product type, end user, and application. Based on the product type, the market is segmented into EP diagnostic catheters, EP ablation catheters, cardiac monitors, EP mapping & recording systems, LAA closure, access devices, and other products. On the basis of end user, the market is segmented on the basis of hospitals, ambulatory surgical center, and electrophysiology labs. By application type, the market includes EP ablation, diagnostic, and surgical. The market growth rate for each segment within the global atrial fibrillation market has been provided after an in-depth research on past trends, future trends demographics, various regulatory requirements, and technological developments.

On the basis of region, the market is segmented on the basis of North America, Europe, Latin America, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). The forecast for each region has been provided for the year 2017-2026, on the basis of product type, end user, and application. The report also provides revenue share and CAGR in form of percentage for each segment.

Global Atrial Fibrillation Market: Competition Landscape

The report provides market share analysis of the key players in the global atrial fibrillation market. The report also offers in-depth information for new entrants and established players to expand geographically and also increase their revenue share. Some of the key players in the report include Biosense Webster, Inc., Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Koninklijke Philips N.V., AtriCure Inc., CardioFocus, Inc., and Osypka AG. 


 
 
Back To Top